Cargando…
DNA damage repair in ovarian cancer: unlocking the heterogeneity
Treatment for advanced ovarian cancer is rarely curative; three quarters of patients with advanced disease relapse and ultimately die with resistant disease. Improving patient outcomes will require the introduction of new treatments and better patient selection. Abrogations in the DNA damage respons...
Autores principales: | Gee, Mary Ellen, Faraahi, Zahra, McCormick, Aiste, Edmondson, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011341/ https://www.ncbi.nlm.nih.gov/pubmed/29925418 http://dx.doi.org/10.1186/s13048-018-0424-x |
Ejemplares similares
-
The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome
por: Walker, Thomas D. J., et al.
Publicado: (2023) -
Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition
por: Middleton, Fiona K., et al.
Publicado: (2015) -
Intragenomic repair heterogeneity of DNA damage.
por: Scicchitano, D A, et al.
Publicado: (1992) -
Functional characterisation of a novel ovarian cancer cell line, NUOC-1
por: McCormick, Aiste, et al.
Publicado: (2017) -
The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis
por: O′Donnell, Rachel L., et al.
Publicado: (2014)